We are live on
!
Find out more
BCM
Brooktree Capital Management Portfolio holdings
AUM
$153M
1-Year Est. Return
14.06%
This Fund
S&P 500
This Quarter
Est. Return
+7.94%
1 Year Est. Return
+14.06%
3 Year Est. Return
+82.89%
5 Year Est. Return
+68.3%
10 Year Est. Return
–
AUM
$156M
AUM Growth
+$6.52M
(+4.4%)
Cap. Flow
-$2.13M
Cap. Flow
% of AUM
-1.37%
Top 10 Holdings %
Top 10 Hldgs %
61.75%
Holding
43
New
1
Increased
11
Reduced
20
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thryv Holdings
THRY
|
+$1.21M |
| 2 |
Rimini Street
RMNI
|
+$998K |
| 3 |
Pfizer
PFE
|
+$675K |
| 4 |
Stryker
SYK
|
+$205K |
| 5 |
Microsoft
MSFT
|
+$127K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPLI
People Inc
PPLI
|
+$4.11M |
| 2 |
Cimpress
CMPR
|
+$383K |
| 3 |
FITB
Fifth Third Bancorp
FITB
|
+$280K |
| 4 |
Apple
AAPL
|
+$280K |
| 5 |
Rocket Companies
RKT
|
+$109K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 44.89% |
| 2 | Financials | 23.33% |
| 3 | Healthcare | 12.33% |
| 4 | Industrials | 11.6% |
| 5 | Consumer Discretionary | 5.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
AbbVie
ABBV
$454B
| $1.9M | 1.22% |
16,878
-73
| -0.4% | -$8.22K |
|
27
PepsiCo
PEP
$186B
| $1.83M | 1.18% |
12,384
-725
| -6% | -$106K |
|
28
Abbott
ABT
$176B
| $1.64M | 1.05% |
14,121
| – | – |
|
29
Lam Research
LRCX
$373B
| $1.47M | 0.94% |
22,520
| – | – |
|
|
30
Rocket Companies
RKT
$37.3B
| $1.17M | 0.75% |
60,692
-5,364
| -8% | -$109K |
|
31
S&P Global
SPGI
$121B
| $1.06M | 0.68% |
2,585
-10
| -0.4% | -$3.84K |
|
32
Lockheed Martin
LMT
$121B
| $704K | 0.45% |
1,860
-50
| -3% | -$19.2K |
|
|
FITB
33
Fifth Third Bancorp
FITB
$49.6B
| $646K | 0.41% |
16,900
-7,000
| -29% | -$280K |
|
|
SHSP
34
DELISTED
SharpSpring, Inc.
SHSP
| $595K | 0.38% |
35,213
-4,768
| -12% | -$72.7K |
|
35
Thermo Fisher Scientific
TMO
$225B
| $523K | 0.34% |
1,037
| – | – |
|
36
Fortune Brands Innovations
FBIN
$4.86B
| $476K | 0.31% |
5,589
| – | – |
|
37
Verisk Analytics
VRSK
$22.9B
| $442K | 0.28% |
2,532
| – | – |
|
38
3M
MMM
$85.1B
| $360K | 0.23% |
2,168
-72
| -3% | -$12K |
|
39
Merck
MRK
$355B
| $268K | 0.17% |
3,447
-165
| -5% | -$12.3K |
|
40
Novartis
NVS
$261B
| $232K | 0.15% |
2,542
| – | – |
|
41
Cummins
CMI
$76.6B
| $213K | 0.14% |
874
| – | – |
|
|
42
Stryker
SYK
$106B
| $208K | 0.13% |
+800
| New | +$205K |
|
|
PPLI
43
People Inc
PPLI
$2.79B
| – | – |
-34,805
| Closed | -$4.11M |
|
Similar funds
RWM
MWA
FFG
PA
PB
DFG
ACM
MVA
Brooktree Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Brooktree Capital Management held 43 positions worth $156M, up 4.4% from $149M the previous quarter. Its ten largest holdings account for 62% of the portfolio.
Trading was light in Q2 2021: portfolio turnover was 4.7%. Brooktree Capital Management opened 1 new position and exited 1, leaving the 43-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 45% of assets, up from 41% a quarter earlier, followed by Financials and Healthcare.
- Brooktree Capital Management's largest Q2 2021 buy was Stryker: 800 shares worth $208K.
- Brooktree Capital Management added most to Thryv Holdings in Q2 2021, an estimated $1.21M increase.
- Brooktree Capital Management's biggest Q2 2021 reduction was Cimpress, cutting an estimated $383K.
- Brooktree Capital Management fully exited People Inc in Q2 2021, selling an estimated $4.11M.
- Brooktree Capital Management's ten largest holdings make up 62% of its $156M portfolio in Q2 2021.
- Brooktree Capital Management opened 1 new position and closed 1 in Q2 2021.
- Brooktree Capital Management's portfolio value rose 4.4% quarter-over-quarter to $156M.
Based on Brooktree Capital Management's 13F filing for Q2 2021, filed 9 Aug 2021.